drug discovery Archives

IPO: Goldman-backed Aragen eyes $150 million as pre-IPO dose; Novo Nordisk keen

IPO: Goldman-backed Aragen eyes 0 million as pre-IPO dose; Novo Nordisk keen

Mumbai: The promoters and investors in Aragen Life Sciences (formerly GVK Bio), the Goldman Sachs-backed contract research organisation (CRO), plan to dilute about 10% stake at a valuation of ₹10,000-12,000 …

How Gorillas And Traditional Healers May Inspire Breakthroughs in Medicine

by Joseph Addison

The findings suggest these plants could lead to the development of new treatments. Scientists believe that gorillas could offer insights into future drug discoveries through their self-medicating behaviour, according to …